Lemonade shares slid 6.5% on Friday, marking the steepest one-day decline in six weeks. Trading volumes reached 228,000 shares by midday, down 91% from the 12-month average of 2.43 million, suggesting muted investor engagement on the downturn. The stock’s 50-day moving average sits near 71, while its 200-day is approximately 56, reflecting a longer-term uptrend that was briefly interrupted.

In its latest quarter, Lemonade reported revenue of $194.5 million, up 42.4% year-over-year and exceeding consensus estimates by over $9 million. Adjusted loss per share narrowed to $0.51, beating forecasts by $0.21, while the firm maintained a negative return on equity of 31.9% and a net margin of minus 26.4%. Management reiterated its target to achieve adjusted EBITDA profitability in 2026, driven by ongoing improvements in underwriting efficiency.

Eight analysts have issued recommendations on Lemonade: one Strong Buy, two Buy, two Hold and three Sell, resulting in a consensus Hold rating. Price targets range widely from the mid-30s to the low-80s, averaging just over 63. Recent revisions include a cut from 60 to 55 by one firm and an increase from 35 to 40 by another, underscoring divergent views on the company’s path to profitability.

Insiders have offloaded 160,725 shares in the past 90 days, representing 14.7% of outstanding stock, with notable sales by both the COO and CFO reducing their stakes by nearly 17–18%. In contrast, large institutions continue to adjust positions: Vanguard increased its holding by 0.9% to over 6.2 million shares, while JPMorgan Chase boosted its stake by 30.8% to 3.5 million shares. Overall, hedge funds and other institutions own about 80% of the float.